Spots Global Cancer Trial Database for metastatic differentiated thyroid cancer
Every month we try and update this database with for metastatic differentiated thyroid cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer | NCT00654238 | Metastatic Diff... Metastatic Poor... Metastatic Anap... Metastatic Medu... | sorafenib | 18 Years - | University of Pennsylvania | |
Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry | NCT05299437 | Metastatic Diff... | Radioiodine opt... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer | NCT00654238 | Metastatic Diff... Metastatic Poor... Metastatic Anap... Metastatic Medu... | sorafenib | 18 Years - | University of Pennsylvania | |
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer | NCT00654238 | Metastatic Diff... Metastatic Poor... Metastatic Anap... Metastatic Medu... | sorafenib | 18 Years - | University of Pennsylvania |